China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-right Heart Catheterization
China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-A Quality Control on Right Heart Catheterization
China-Japan Friendship Hospital
10,000 participants
Jan 1, 2018
OBSERVATIONAL
Conditions
Summary
Right heart catheterization(RHC) plays a crucial role in the diagnosis and treatment of pulmonary vascular diseases(PVD). In China, the lack of equipment and technical expertise has historically limited the implementation of RHC, thereby greatly restricting the diagnosis and treatment of RVD. In recent years, with improvements in these issues, more hospitals have acquired the capability to perform RHC. The purpose of this study is to conduct quality control of RHC across multiple pulmonary hypertension(PH) centers in China. The study population consists of patients who underwent RHC for the first time due to dyspnea or suspected PH. This study retrospectively and prospectively collects multicenter RHC data, with the main quality control contents including indications for the procedure, collection and analysis of hemodynamic data, diagnosis and treatment, and long-term management of patients.
Eligibility
Inclusion Criteria2
- Patients who underwent right heart catheterization for the first time due to dyspnea or suspected pulmonary hypertension
- Age ≥14 years old
Exclusion Criteria2
- Vital data missing
- Did not sign informed consent or did not agree to follow-up
Interventions
No intervention; observational study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06954727